Used for: Acid reflux, GERD, heartburn
What the research shows:
A 2025 Mendelian randomization study found that lansoprazole was associated with a significantly increased risk of Alzheimer’s disease and all-cause dementia. Another common PPI, omeprazole, showed mixed results—increased risk for frontotemporal dementia but possible protective effects for vascular dementia.
What to do: PPIs are often overprescribed and used for longer than necessary. Ask your doctor if you still need them, or if you can try:
-
Lower doses
-
“On-demand” use (only when symptoms occur)
-
H2 blockers (famotidine/Pepcid) which may have lower risk
-
Lifestyle changes (elevating head of bed, avoiding late meals)
💧 6. Overactive Bladder Medications
Used for: Urgency, frequency, incontinence
What the research shows:
The Swedish study found that urinary antispasmodics were among the drug classes most strongly associated with dementia risk. These include:
-
Oxybutynin (Ditropan) – highest risk
-
Tolterodine (Detrol)
-
Solifenacin (Vesicare)
-
Trospium
What to do: Ask about newer overactive bladder medications like mirabegron (Myrbetriq) , which works through a different mechanism and does not have anticholinergic effects. Non-drug options include pelvic floor therapy and bladder training.
🤧 7. First-Generation Antihistamines (Benadryl, Chlor-Trimeton)
Used for: Allergies, colds, sleep, itching
What the research shows:
These older antihistamines cross the blood-brain barrier and block acetylcholine in the brain. Studies consistently link long-term use to cognitive decline.
Examples:
-
Diphenhydramine (Benadryl, Tylenol PM, ZzzQuil, Advil PM)
-
Chlorpheniramine (Chlor-Trimeton)
-
Hydroxyzine (Atarax, Vistaril)
-
Doxylamine (Unisom, NyQuil)
What to do: For allergies, switch to second-generation antihistamines like cetirizine (Zyrtec) , loratadine (Claritin) , or fexofenadine (Allegra) , which do not cross the blood-brain barrier as readily. For sleep, try non-pharmacological approaches first.
🧠 8. Statins (Controversial—Read This Carefully)
Used for: High cholesterol, heart disease prevention
This is the most debated category—and the evidence has shifted significantly.
What the research shows:
A 2015 meta-analysis of 23 randomized controlled trials (29,012 participants) found no significant adverse effects of statins on cognition in either cognitively normal subjects or those with Alzheimer’s disease.
The FDA’s 2012 warning about cognitive side effects was based primarily on case reports and post-marketing surveillance—not randomized controlled trials. The meta-analysis authors concluded that the FDA warning “may no longer be warranted”.
The bottom line: For most people, the cardiovascular benefits of statins (preventing heart attack and stroke) far outweigh any potential cognitive risks. Don’t stop your statin due to dementia fears without talking to your doctor—the proven benefits are substantial.
What to do: If you notice cognitive changes after starting a statin, discuss it with your doctor. They may consider switching to a different statin (lipophilic statins like atorvastatin cross the blood-brain barrier more than hydrophilic statins like pravastatin). But don’t stop on your own.
ADVERTISEMENT
